Graduation Project
Start Date : 15 May 2025-14 Jun 2025
This project investigates the development of nanocarriers loaded with herbal anticancer agents to enhance solubility, stability, and targeted delivery to lung tissue. The Nano formulations are designed to improve therapeutic efficacy while minimizing systemic toxicity and side effects. Emphasis is placed on evaluating cytotoxicity, tumor-targeting efficiency, and molecular mechanisms of action, highlighting the role of natural products in complementary cancer therapy.

Graduation Project
Start Date : 15 May 2025-14 Jun 2025
This project explores the use of nanotechnology-based delivery systems to enhance the bioavailability and pulmonary delivery of herbal agents with anti-inflammatory, antimicrobial, and immunomodulatory properties. The aim is to provide sustained release, better lung deposition, and targeted action against Mycobacterium tuberculosis and airway inflammation in asthma. The approach seeks to offer safer and more effective alternatives or adjuncts to conventional treatments by harnessing the potential of natural products in respiratory diseases.

Graduation Project
Start Date : 12 Nov 2024-12 Dec 2024
This project focuses on designing and optimizing lipid-polymer hybrid nanoparticles (LPHNs) as multifunctional drug delivery platforms for cancer treatment. By combining the structural stability of polymers with the biocompatibility and high drug-loading capacity of lipids, the system aims to overcome limitations of conventional nanocarriers. The hybrid systems are engineered for tumor-targeted delivery, sustained drug release, and improved pharmacokinetics.